Bibliographic Details
| Title: |
PANcreatic-DERived factor: Novel hormone PANDERing to glucose regulation |
| Authors: |
Wilson, Camella G.1, Robert-Cooperman, Claudia E.2, Burkhardt, Brant R.2,3 bburkhardt@usf.edu |
| Source: |
FEBS Letters. Jul2011, Vol. 585 Issue 14, p2137-2143. 7p. |
| Subjects: |
Islands of Langerhans, Cytokines, Glucose, Gene expression, Apoptosis, Treatment of diabetes, Animal models in research |
| Abstract: |
Abstract: PANcreatic-DERived factor (PANDER, FAM3B) is a member of the FAM3 family of cytokine molecules that were initially described in 2002. PANDER expression is primarily localized to the endocrine pancreas and is secreted from both pancreatic α and β-cells. Initial characterization of PANDER revealed a potential role in pancreatic islet apoptosis. However, recent animal models have indicated PANDER functions as a hormone by regulating glucose levels via interaction with both the liver and the endocrine pancreas. An understanding of the function of PANDER can further the insight into the mechanisms of glucose regulation and potentially provide additional therapeutic targets for the treatment of diabetes. This review details the supporting data demonstrating PANDER has a biological function in glycemic regulation. [Copyright &y& Elsevier] |
|
Copyright of FEBS Letters is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Engineering Source |
